A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndrome.
Peeling skin syndrome is an autosomal recessive genodermatosis characterized by the shedding of the outer epidermis. In the acral form, the dorsa of the hands and feet are predominantly affected. Ultrastructural analysis has revealed tissue separation at the junction between the granular cells and the stratum corneum in the outer epidermis. Genomewide linkage analysis in a consanguineous Dutch kindred mapped the gene to 15q15.2 in the interval between markers D15S1040 and D15S1016. Two homozygous missense mutations, T109M and G113C, were found in TGM5, which encodes transglutaminase 5 (TG5), in all affected persons in two unrelated families. The mutation was present on the same haplotype in both kindreds, indicating a probable ancestral mutation. TG5 is strongly expressed in the epidermal granular cells, where it cross-links a variety of structural proteins in the terminal differentiation of the epidermis to form the cornified cell envelope. An established, in vitro, biochemical cross-linking assay revealed that, although T109M is not pathogenic, G113C completely abolishes TG5 activity. Three-dimensional modeling of TG5 showed that G113C lies close to the catalytic domain, and, furthermore, that this glycine residue is conserved in all known transglutaminases, which is consistent with pathogenicity. Other families with more-widespread peeling skin phenotypes lacked TGM5 mutations. This study identifies the first causative gene in this heterogeneous group of skin disorders and demonstrates that the protein cross-linking function performed by TG5 is vital for maintaining cell-cell adhesion between the outermost layers of the epidermis.
Cassidy
Andrew J
AJ
Epithelial Genetics Group, Human Genetics Unit, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, United Kingdom.
van Steensel
Maurice A M
MA
Steijlen
Peter M
PM
van Geel
Michel
M
van der Velden
Jaap
J
Morley
Susan M
SM
Terrinoni
Alessandro
A
Melino
Gerry
G
Candi
Eleonora
E
McLean
W H Irwin
WH
D001665:Binding Sites; D020134:Catalytic Domain; D002460:Cell Line; D002874:Chromosome Mapping; D003241:Consanguinity; D003429:Cross Reactions; D004252:DNA Mutational Analysis; D004817:Epidermis / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D005260:Female; D005808:Genes, Recessive; D008040:Genetic Linkage; D005819:Genetic Markers; D005822:Genetic Vectors; D006239:Haplotypes; D006720:Homozygote; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats; D008958:Models, Molecular; D008969:Molecular Sequence Data; D020125:Mutation, Missense; D010375:Pedigree; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D017422:Sequence Analysis, DNA; D012871:Skin Diseases / Q000201:enzymology* / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D013577:Syndrome; D011503:Transglutaminases / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism
D005819:Genetic Markers; C418703:transglutaminase 5; D011503:Transglutaminases